{"id":15909,"date":"2020-12-18T12:01:05","date_gmt":"2020-12-18T11:01:05","guid":{"rendered":"https:\/\/idibell.cat\/es\/?p=15909"},"modified":"2020-12-18T12:01:24","modified_gmt":"2020-12-18T11:01:24","slug":"el-tratamiento-con-hierro-reduce-el-riesgo-de-hospitalizacion-en-personas-con-deficiencias-cardiacas","status":"publish","type":"post","link":"https:\/\/idibell.cat\/es\/2020\/12\/el-tratamiento-con-hierro-reduce-el-riesgo-de-hospitalizacion-en-personas-con-deficiencias-cardiacas\/","title":{"rendered":"El tratamiento con hierro reduce el riesgo de hospitalizaci\u00f3n en personas con deficiencias card\u00edacas"},"content":{"rendered":"<p>El Dr. Josep Com\u00edn, jefe del grupo del enfermedades cardiovasculares del IDIBELL y jefe del servicio de cardiolog\u00eda del Hospital Universitario de Bellvitge (HUB), \u00a0ha participado en el estudio \u201cAFFIRM-AHF\u201d. Este estudio eval\u00faa el efecto del tratamiento con hierro carboximaltosa en las hospitalizaciones por insuficiencia card\u00edaca y en la mortalidad cardiovascular en pacientes con d\u00e9ficit de hierro, despu\u00e9s de su estabilizaci\u00f3n por ingreso de insuficiencia card\u00edaca aguda.<\/p>\n<p>Los resultados, dados a conocer de forma simult\u00e1nea en el congreso virtual de la American Heart Association (AHA) 2020 y en la revista &#8216;<a href=\"https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(20)32339-4\/fulltext\">The Lancet<\/a>&#8216;, muestran que los pacientes que recibieron el suplemento de hierro ten\u00edan un 26% menos de probabilidades de ser reingresados en el hospital por insuficiencia card\u00edaca respecto al grupo de control.<\/p>\n<p>El estudio cont\u00f3 con 1.108 pacientes de 15 pa\u00edses diferentes que fueron dados de alta despu\u00e9s de ser hospitalizados por una insuficiencia card\u00edaca aguda y a los cu\u00e1les se les detect\u00f3 niveles bajos de hierro en su estancia en el hospital. Los participantes fueron divididos en dos grupos, uno recibi\u00f3 el tratamiento con hierro y otro recibi\u00f3 placebo. Despu\u00e9s de 52 semanas, esos pacientes que hab\u00edan recibido el suplemento de hierro mostraron menos probabilidades de volver a ser ingresados en el hospital.<\/p>\n<p>&nbsp;<\/p>\n<p><em>El Instituto de Investigaci\u00f3n Biom\u00e9dica de Bellvitge (IDIBELL) es un centro de investigaci\u00f3n en biomedicina creado en 2004. Est\u00e1 participado por el Hospital Universitario de Bellvitge y el Hospital de Viladecans del Instituto Catal\u00e1n de la Salud, el Instituto Catal\u00e1n de Oncolog\u00eda, la Universidad de Barcelona y el Ayuntamiento de L&#8217;Hospitalet de Llobregat.<\/em><\/p>\n<p><em>El IDIBELL es miembro del Campus de Excelencia Internacional de la Universidad de Barcelona HUBc y forma parte de la instituci\u00f3n CERCA de la Generalitat de Catalunya. En 2009 se convirti\u00f3 en uno de los cinco primeros centros de investigaci\u00f3n espa\u00f1oles acreditados como instituto de investigaci\u00f3n sanitaria por el Instituto de Salud Carlos III. Adem\u00e1s, forma parte del programa \u00abHR Excellence in Research\u00bb de la Uni\u00f3n Europea y es miembro de EATRIS y REGIC. Desde el a\u00f1o 2018, IDIBELL es un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Los resultados, dados a conocer de forma simult\u00e1nea en el congreso virtual de la American Heart Association (AHA) 2020 y en la revista &#8216;The Lancet&#8217;, muestran que los pacientes que recibieron el suplemento de hierro ten\u00edan un 26% menos de probabilidades de ser reingresados en el hospital por insuficiencia card\u00edaca respecto al grupo de control.<\/p>\n","protected":false},"author":8,"featured_media":15910,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[186,309,308],"tags":[],"class_list":["post-15909","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-area-medicina-traslacional","category-enfermedades-cardiovasculares","category-programa-de-enfermedades-cardiovasculares-respiratorias-sistemicas-y-de-envejecimiento-celular"],"publishpress_future_action":{"enabled":false,"date":"2024-09-15 01:10:17","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/15909"}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=15909"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/15909\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media\/15910"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=15909"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/categories?post=15909"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/tags?post=15909"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}